Page 5 - Hong Kong (HSI) Pharmaceuticals & Biotech Stocks - Biggest Losers Today

UPDATED Dec 24, 2025

Explore the Hong Kong (HSI) Biggest Losers Today. These Pharmaceuticals & Biotech Stocks have seen the largest drop in Market Cap from the previous trading day.

122 companies
CompanyLast Price1D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
2005
SSY Group
HK$2.940.3%-17.9%HK$8.5bHK$3.99PE13xE13.2%4.9%
1652
Fusen Pharmaceutical
HK$0.805.3%-1.2%HK$591.4mn/aPS2.2xn/a0%
2161
JBM (Healthcare)
HK$2.721.5%47.0%HK$2.2bHK$3.53PE10.3xE14.5%7.2%
6660
AIM Vaccine
HK$3.430.9%-44.0%HK$4.2bHK$10.96PS3xS60.7%n/a
2877
China Shineway Pharmaceutical Group
HK$8.750.6%-11.9%HK$6.6bHK$8.54PE7.2xE4.8%6.0%
1244
3D Medicines
HK$4.763.9%42.5%HK$1.2bn/aPS2.3xn/an/a
2480
Beijing Luzhu Biotechnology
HK$23.601.0%6.1%HK$4.7bHK$31.77PB5.7xE105.9%n/a
2552
Hua Medicine (Shanghai)
HK$3.181.6%110.6%HK$3.1bHK$6.00PE2.6xE-89.8%n/a
719
Shandong Xinhua Pharmaceutical
HK$6.720.6%15.1%HK$10.0bn/aPE10.9xS7.4%4.5%
1541
ImmuneOnco Biopharmaceuticals (Shanghai)
HK$6.202.3%21.1%HK$2.7bHK$21.89PS19.6xS30.2%n/a
1011
China NT Pharma Group
HK$0.9310.7%238.2%HK$627.0mn/aPS30.3xn/a0%
1666
Tong Ren Tang Technologies
HK$4.461.4%-13.1%HK$5.7bHK$6.20PE11.9xE16.4%4.4%
2630
Vigonvita Life Sciences
HK$84.201.4%n/aHK$5.6bn/aPS428xn/an/a
1801
Innovent Biologics
HK$80.750.06%125.6%HK$139.0bHK$110.40PE110.7xE28.3%n/a
570
China Traditional Chinese Medicine Holdings
HK$2.160.9%-6.5%HK$10.9bHK$1.60PB0.5xS4.2%0.2%
2511
HighTide Therapeutics
HK$3.055.9%156.3%HK$1.7bn/aPB5xn/an/a
1167
Jacobio Pharmaceuticals Group
HK$7.602.6%517.9%HK$6.0bHK$9.50PS26.8xS-25.8%n/a
6990
Sichuan Kelun-Biotech Biopharmaceutical
HK$419.200.2%144.9%HK$97.8bHK$532.56PS58.8xE55.7%n/a
1672
Ascletis Pharma
HK$12.611.7%304.2%HK$12.5bHK$21.13PS4773.3xE-5.4%n/a
2591
Guangzhou Innogen Pharmaceutical Group
HK$32.181.5%n/aHK$14.7bn/aPS234.9xn/an/a
2652
CF PharmTech
HK$35.062.0%n/aHK$14.4bn/aPE469.5xn/an/a
1875
BioDlink International
HK$2.5019.0%56.3%HK$1.9bn/aPE240.1xn/an/a
2637
Fujian Haixi Pharmaceuticals
HK$139.004.7%n/aHK$10.9bn/aPE72.5xn/an/a
2565
PegBio
HK$65.004.4%n/aHK$18.1bn/aPB64.1xn/an/a
Page 5 of 6